Vaxcyte
Stock Forecast, Prediction & Price Target

Vaxcyte Financial Estimates

Vaxcyte Revenue Estimates

Vaxcyte EBITDA Estimates

Vaxcyte Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $21.42M
Low: $21.42M
High: $21.42M
avg. 0%
Avg: $92.76M
Low: $92.76M
High: $92.76M
avg. 332.88%
Avg: $340.02M
Low: $340.02M
High: $340.02M
avg. 266.56%
Net Income
 
% change YoY
$-100.08M
 
N/A
$-239.64M
 
-139.43%
$-402.26M
 
-67.86%
Avg: $-506.68M
Low: $-461.49M
High: $-321.59M
avg. -25.95%
Avg: $-540.14M
Low: $-522.70M
High: $-276.89M
avg. -6.60%
Avg: $-392.51M
Low: $-392.51M
High: $-392.51M
avg. 27.33%
Avg: $-262.08M
Low: $-262.08M
High: $-262.08M
avg. 33.23%
EBITDA
 
% change YoY
$-98.28M
 
N/A
$-189.77M
 
-93.09%
$-464.88M
 
-144.96%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$1.93
 
N/A
-$3.69
 
-91.19%
-$4.14
 
-12.19%
Avg: -$4.34
Low: -$4.75
High: -$3.31
avg. -4.85%
Avg: -$4.42
Low: -$5.38
High: -$2.85
avg. -1.91%
Avg: -$4.04
Low: -$4.04
High: -$4.04
avg. 8.68%
Avg: -$2.7
Low: -$2.7
High: -$2.7
avg. 33.23%
Operating Expenses
 
% change YoY
$102.08M
 
N/A
$207.33M
 
103.09%
$468.04M
 
125.74%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Vaxcyte stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 7.00% in 2025-2028.

We have gathered data from 7 analysts. Their low estimate is -461.49M, average is -506.68M and high is -321.59M.

What is Vaxcyte stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 149.86% in 2025-2028.

We have gathered data from 8 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Vaxcyte stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 8.78% in 2025-2028.

We have gathered data from 7 analysts. Their low earnings per share estimate is -$4.75, average is -$4.34 and high is $-3.31.

What is the best performing analyst?

In the last twelve months analysts have been covering Vaxcyte stock. The most successful analyst is Roger Song.